Spironolactone Improves the All-Cause Mortality and Re-Hospitalization Rates in Acute Myocardial Infarction with Chronic Kidney Disease Patients

• Main Authors: Xiang Qu (Author), Hui Yao (Author), Changxi Chen (Author), Shuting Kong (Author), Lingyue Sun (Author), Leilei Du (Author), Siqi Liang (Author), Zhan Gao (Author), Gaoshu Zheng (Author), Minghua Zheng (Author), Chuhuan Zhao (Author), Xiafei Feng (Author), Gaojun Wu (Author), Hao Zhou (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Mineralocorticoid receptor antagonists (MRA) improve outcomes in chronic kidney disease (CKD) and acute myocardial infarction (AMI) patients. However, the lack of evidence regarding long-term clinical outcomes in the use of MRA, including spironolactone, in patients with AMI combined wit...